Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial

Csaba Polgár(National Institute of Oncology), Oliver J. Ott(Universitätsklinikum Erlangen), Guido Hildebrandt(University of Rostock), Daniela Kauer-Dorner(Vienna General Hospital), Hellen Knauerhase(University of Rostock), Tibor Major(National Institute of Oncology), Jarosław Łyczek(Centrum Onkologii), José Luis Guinot(Fundación Instituto Valenciano de Oncología), Jürgen Dunst(University Hospital Schleswig-Holstein), Cristina Gutiérrez Miguélez(Institut Català d'Ornitologia), Pavel Šlampa(Masaryk Memorial Cancer Institute), Michael Allgäuer(Krankenhaus Barmherzige Brüder), Kristina Lössl(University Hospital of Bern), Bülent Polat(Universitätsklinikum Würzburg), György Kovács(University Hospital Schleswig-Holstein), Arnt-René Fischedick(Clemenshospital Münster), Rainer Fietkau(University of Rostock), Alexandra Resch(Vienna General Hospital), Anna Kulik(Centrum Onkologii), Leo Arribas(Fundación Instituto Valenciano de Oncología), Peter Niehoff(University of Lübeck), Ferrán Guedea(Institut Català d'Oncologia), Annika Schlamann(University Hospital Leipzig), Richard Pötter(Vienna General Hospital), Christine M. Gall(Friedrich-Alexander-Universität Erlangen-Nürnberg), Wolfgang Uter(Friedrich-Alexander-Universität Erlangen-Nürnberg), Vratislav Strnad(Universitätsklinikum Erlangen)
The Lancet Oncology
January 13, 2017
Cited by 255

Abstract


Related Papers

No related papers found

Powered by citation graph analysis